Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 The presence and immunolocalization of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in human atheroma. Consecutive sections from human atherosclerotic plaque where TRAIL (lower right panel), oxidized low-density lipoprotein (oxLDL) (lower left panel), and CD3 (upper left panel) represent the corresponding primary antibody used. The upper right panel is a Masson's trichrome stain of fibrotic tissues and discriminates the fibrous cap from the lipid core.
|
